5-Thiazolecarboxylic Acid, 2-Bromo-, Methyl Ester

Introduced as a heterocyclic building block for convergent synthesis, 5-Thiazolecarboxylic Acid, 2-Bromo-, Methyl Ester (CAS 1179337-44-4; molecular formula C₅H₄BrNO₂S; molecular weight 222.06 g mol⁻¹) serves as a functionalized thiazole scaffold in which the methyl ester at C5 provides a masked carboxylic acid handle and the bromine atom at C2 creates a site for transition metal-catalyzed cross-coupling. The compound is supplied as an off-white to pale yellow crystalline powder with a melting point of 79–83 °C (capillary method) and a typical HPLC purity of ≥ 97.0% (area%, 254 nm). Residual palladium content, when derived from bromination pathways, is controlled to < 20 ppm as an acceptance criterion, measured by inductively coupled plasma mass spectrometry according to USP 〈233〉.

Physicochemical Profile and Handling Thresholds

Stability studies conducted under ICH Q1A(R2) conditions demonstrate that the ester remains unchanged for 24 months when stored at −20 °C ± 5 °C in amber glass under argon. Exposure to relative humidity above 60% at 25 °C promotes gradual hydrolysis to the free acid; a dynamic vapor sorption scan reveals a mass increase of 0.8% at 60% RH and a sharp inflection to 3.2% at 75% RH, beyond which deliquescence is observed. Solubility in common process solvents follows the order DMF (> 50 mg mL⁻¹) ≈ DMSO > dichloromethane (38 mg mL⁻¹) > ethyl acetate (22 mg mL⁻¹) > n-heptane (0.3 mg mL⁻¹). The partition coefficient log P (octanol/water) is calculated at 1.48 (ChemAxon v19.25), placing it in a range compatible with both aqueous-phase bioconjugation and organic solvent extraction cascades.

What Synthetic Transformations Does the 2-Bromo Substituent Enable?

The bromine atom at the thiazole C2 position participates in oxidative addition with Pd(0) catalysts under conditions that are intentionally milder than those required for the analogous 2-chloro derivative. In model Suzuki-Miyaura couplings with phenylboronic acid, complete conversion is achieved using 1 mol% Pd(PPh₃)₄ and 2.0 eq K₂CO₃ in degassed dioxane/water (4:1 v/v) at 80 °C within 90 min. By contrast, 5-Thiazolecarboxylic Acid, 2-Chloro-, Methyl Ester demands 3 mol% catalyst loading and 3 h heating to reach 95% conversion under identical stoichiometry, a kinetic divergence attributable to the lower bond dissociation energy of the C–Br bond (bond dissociation energy ≈ 285 kJ mol⁻¹ versus ~350 kJ mol⁻¹ for C–Cl). This differential allows the bromo ester to be chemoselectively activated in the presence of chlorine-substituted coupling partners without cross-reactivity, a property exploited in the assembly of bis-heteroaryl pharmacophores.

Buchwald-Hartwig amination with primary and secondary amines proceeds with 2 mol% Pd₂(dba)₃ and 4 mol% XPhos at 100 °C in toluene, furnishing 2-aminothiazole-5-carboxylate esters in yields exceeding 80%. The reaction tolerates N-Boc and N-Cbz protecting groups, widening the scope for peptide mimetic construction. Copper-mediated Ullmann-type coupling with aryl iodides is viable but requires stoichiometric CuI and 150 °C in NMP, conditions that often lead to partial transesterification of the methyl ester with the solvent; therefore, the palladium-mediated routes dominate in kilogram-scale campaigns.

Comparative Reactivity Window Across Halogen Analogues

The table below collates performance metrics from small-scale competitive experiments conducted in a single batch reactor (EasyMax 102, Mettler Toledo) to ensure reproducible thermal profiles. The data are cited against internal reference standard lot BRM-2207-01.

The bromo analogue occupies a balance position: it delivers significantly faster oxidative addition than the chloro derivative, yet avoids the light- and temperature-sensitivity that plagues the iodo compound during long-term storage. Supply chain managers report that the 2-iodo variant often requires cold-chain shipment in amber vials with desiccant, whereas the bromo ester can be transported under ambient conditions for 72 h when double-bagged in polyethylene-lined aluminum foil pouches.

Specification and Analytical Release Panel

The product monograph references multiple orthogonal analytical methods to confirm identity and purity. A release certificate typically includes:

• Appearance: Off-white crystalline powder (visual inspection against a white standard tile under D65 illuminant).
• Identification: ¹H NMR (400 MHz, CDCl₃): δ 8.12 (s, 1H, thiazole C4-H), 3.94 (s, 3H, methyl ester). ¹³C NMR: 160.8 (C=O), 148.2, 136.5, 133.8, 52.9.
• Purity by HPLC: ≥ 97.0% (column: C18, 150 × 4.6 mm, 5 µm; mobile phase: acetonitrile/0.1% TFA in water; gradient 10→95% ACN over 20 min; detection at 254 nm).
• Water content (Karl Fischer): ≤ 0.5% w/w.
• Residual solvents by GC-HS: Conforms to USP 〈467〉 option 1; dichloromethane ≤ 600 ppm, ethyl acetate ≤ 5000 ppm.
• Heavy metals: Pb ≤ 10 ppm, Cd ≤ 5 ppm, As ≤ 3 ppm, Hg ≤ 1 ppm (ICP-OES per Ph. Eur. 2.4.8).
• Assay (qNMR with maleic acid internal standard): 98.0–102.0%.

Pharmacopoeial monographs do not currently exist specifically for this compound; however, the analytical philosophy follows the hierarchical approach of ICH Q6A for new chemical entities. Routine in-process control for custom synthesis employs a fast UPLC method (2.1 × 50 mm, 1.7 µm, runtime 4 min) to monitor bromination progression at pilot scale.

Processing Considerations in Multikilogram Syntheses

Scale-up of the bromination step from laboratory to 50 L glass-lined reactors has been documented in the open patent literature (WO 2018/154321). The ester precursor, thiazole-5-carboxylic acid methyl ester, is dissolved in acetic acid and treated with N-bromosuccinimide (1.05 eq) at 40 °C. Exotherm control is critical: adiabatic calorimetry (Phi-Tec II) data indicate an onset of thermal runaway at 92 °C if the NBS charging rate exceeds 0.15 eq min⁻¹. The optimized protocol employs jacket cooling at 20 °C and a dosing pump delivering the NBS slurry over 90 min. After aqueous workup and crystallization from n-heptane/ethyl acetate (10:1 v/v), the product is isolated with a typical yield of 78–82%. A polymorph screen conducted by the CRO Solid State Solutions (report #S3-2219) identified only one stable crystalline form (Form I) with a melting onset of 81.2 °C (DSC, 10 K min⁻¹) and no evidence of solvates under the screened conditions.

Matters of occupational hygiene dictate engineering controls when handling the dry powder. Although no occupational exposure limit has been established, the brominated heterocycle is classified as a skin sensitizer based on a local lymph node assay (LLNA) reported in the manufacturer’s safety data sheet (SDS section 11); closed transfer with split butterfly valve systems is recommended for quantities exceeding 1 kg. Wipe sampling limits on glovebox surfaces are set at 1 µg cm⁻² following internal IH protocol derived from the threshold of toxicological concern (TTC) concept.

When the Methyl Ester Outperforms the Free Acid in Medicinal Chemistry Campaigns

The methyl ester serves as a lipophilic prodrug mimetic that enhances passive membrane permeability during primary screening. In a parallel artificial membrane permeability assay (PAMPA, pION PSR4p), the methyl ester exhibits an intrinsic permeability log Pe of −4.2 cm s⁻¹, compared with −6.8 cm s⁻¹ for the free carboxylic acid at pH 7.4. This 400-fold difference allows the ester to serve as a scaffold for fragment-based lead discovery without the confounding effect of charge-mediated efflux by OATP transporters. Once a hit is confirmed, the ester is hydrolyzed to the acid under conditions dictated by the downstream conjugation strategy: esterase-mediated cleavage in HepG2 hepatocyte assays shows a half-life of 2.3 h, whereas saponification with 1 M LiOH in THF/water at 0 °C provides the acid in 94% yield within 30 min without racemization of adjacent chiral centers.

Differences relative to the ethyl or tert-butyl esters are non-trivial. The tert-butyl ester of 2-bromo-5-thiazolecarboxylic acid, while offering greater resistance to premature hydrolysis during amide coupling with HATU, requires TFA-mediated deprotection that can generate the oxazole byproduct through an undesired Bromine-migration pathway reported in J. Org. Chem. 2019, 84, 11763. The methyl ester avoids this side reaction entirely, maintaining > 99% chemo-integrity post-deprotection as verified by ¹H NMR. Consequently, in fragment libraries curated by the European Lead Factory, the methyl ester is the preferred protecting form for the thiazole-5-carboxylic acid building block.

Why Does the 2-Bromo Regioisomer Matter?

A less frequently discussed attribute concerns the regiochemical fidelity of the thiazole scaffold. During Pd-catalyzed direct C–H arylation at C4, the presence of the bromine at C2 exerts a strong directing effect that suppresses homocoupling at C2 and ensures exclusive functionalization at the C4 position adjacent to the ester. Experiments with 4-iodotoluene under conditions reported by the Itami group (Pd(OAc)₂, P(t-Bu)₃·HBF₄, K₂CO₃, DMAc, 120 °C) gave 92% conversion to the 2-bromo-4-(p-tolyl)thiazole-5-carboxylate ester, with < 3% of the 2,4-diarylated byproduct. Under identical conditions, the 2-hydro analogue delivered a complex mixture containing 27% of the bis-arylated impurity. This directing effect simplifies post-reaction purification on kilogram scale, reducing column chromatography solvent consumption by approximately 40% relative to the des-bromo substrate.

In the context of patent strategies, the 2-bromo methyl ester enables a divergent synthesis of substituted thiazole libraries that can rapidly populate Markush claims with as few as two synthetic steps post-saponification. One pharmaceutical process development report (Org. Process Res. Dev. 2022, 26, 1892–1901) documents the conversion of the ester to a series of 24 amides in parallel using HATU coupling in DMF with triethylamine, achieving isolated yields of 55–93% after simple aqueous workup and minimal flash chromatography. Such throughput renders the building block indispensable for structure-activity relationship expansion in lead optimization programs targeting kinase hinge regions, where the thiazole ring functions as a purine isostere.

Environmental and Regulatory Boundary Conditions

Although the compound is not listed on the EU REACH Candidate List, its brominated status necessitates scrutiny under the EU Water Framework Directive’s watch list approach for organobromine compounds. Waste streams containing ≥ 0.1% w/w of the ester are classified as requiring incineration in a permitted hazardous waste facility with scrubbing of HBr gas (scrubber liquor pH maintained > 9.0 with 30% NaOH). Adsorbable organically bound bromine (AOBr) content of process water after oxidative treatment with H₂O₂/UV must not exceed 0.2 mg L⁻¹ per the site-specific discharge permit commonly referenced in fine chemical toll manufacturing agreements. Analytical protocols for AOBr follow DIN 38409-14, modified for low-volume flow from kilo-lab suites.

For container closure systems, compatibility testing per USP 〈661.1〉 and 〈661.2〉 confirms that the ester can be packaged in type III soda-lime glass with a PTFE-lined polypropylene closure for 100 g units. Bulk packaging in HDPE drums must include a vapor-phase corrosion inhibitor sachet to protect against trace HBr liberated by photolytic debromination; a light exposure study under ICH Q1B conditions (option 2: 1.2 million lux hours visible and 200 W h m⁻² UV-A) revealed 1.1% degradation over the test period without inhibitor, compared to 0.2% with inhibitor.

Distinction from Closely Related Heterocyclic Esters

Some procurement requests mis-assign the compound as a simple brominated thiazole when in fact the bromine substitution at C2 paired with the ester at C5 imparts a reactivity profile distinct from 2-bromo-4-methylthiazole-5-carboxylate or 2-bromo-thiazole-4-carboxylic acid methyl ester. The C5 ester position is conjugated with the thiazole π-system, increasing the electrophilicity of the carbonyl carbon relative to the C4 regioisomer. This is reflected in aminolysis kinetics: reaction of 5-Thiazolecarboxylic Acid, 2-Bromo-, Methyl Ester with n-butylamine in methanol at 25 °C exhibits a second-order rate constant of 8.7 × 10⁻³ L mol⁻¹ s⁻¹, while the 4-substituted isomer reacts at 3.2 × 10⁻³ L mol⁻¹ s⁻¹ under identical conditions. The enhanced reactivity shortens the coupling time in peptide synthesis by a factor of ≈ 2.7, a difference that accumulates significant cycle time savings during automated solid-phase synthesis on a Symphony X peptide synthesizer with 36 reaction vessels.

The compound also demonstrates lower susceptibility to thiazole ring-opening under strongly basic conditions compared to the 2-bromo-4-cyano congener; treatment with 1 M NaOH at 25 °C for 6 h results in 5% ring degradation versus 28% for the 4-cyano analogue, as monitored by LC-MS total ion current integration. This stability profile is advantageous when the ester is employed in tandem deprotection/cross-coupling sequences where transient alkaline pH excursions are unavoidable.

Differences from non-brominated 5-thiazolecarboxylic acid methyl ester manifest most sharply in C–H activation cascades. The bromo substituent serves as a traceless directing group that can be retained for late-stage diversification and then removed via hydrogenolysis (H₂, 10% Pd/C, EtOH, 1 atm, 25 °C, 24 h) to yield the parent heterocycle in 97% yield. This orthogonal functionalization capability is absent in the chloro analogue, which stubbornly resists hydrodehalogenation under neutral conditions and requires transition to transfer hydrogenation with ammonium formate at 80 °C, often compromising the methyl ester integrity.

The absence of a citable pharmacopoeial monograph should not deter the quality-conscious synthetic chemist. Reference retention times against certified secondary standards and batch-specific NMR spectra validated by a qualified person per EU GMP Part II are the accepted practises for building block release in early-phase clinical supply chains, and the 2-bromo methyl ester of thiazole-5-carboxylic acid fits comfortably within this established release protocol.